My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 488

    1.

    Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.

    Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y.

    Diabetes. 2006 Aug;55(8):2245-55.PMID: 16873687 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

    Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, Nowygrod S, Wolf BM, Caliste X, Yan SF, Stern DM, Schmidt AM.

    Am J Pathol. 2001 Aug;159(2):513-25.PMID: 11485910 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia.

    Zaccagnini G, Gaetano C, Della Pietra L, Nanni S, Grasselli A, Mangoni A, Benvenuto R, Fabrizi M, Truffa S, Germani A, Moretti F, Pontecorvi A, Sacchi A, Bacchetti S, Capogrossi MC, Farsetti A.

    J Biol Chem. 2005 Apr 15;280(15):14790-8. Epub 2005 Feb 1.PMID: 15687494 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3.

    Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, Hsu DK, Liu FT, Thorpe SR, Gardiner TA.

    Diabetes. 2005 Mar;54(3):785-94.PMID: 15734857 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.

    Harashima A, Yamamoto Y, Cheng C, Tsuneyama K, Myint KM, Takeuchi A, Yoshimura K, Li H, Watanabe T, Takasawa S, Okamoto H, Yonekura H, Yamamoto H.

    Biochem J. 2006 May 15;396(1):109-15.PMID: 16503878 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Central role of RAGE-dependent neointimal expansion in arterial restenosis.

    Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y.

    J Clin Invest. 2003 Apr;111(7):959-72.PMID: 12671045 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.

    Okamoto T, Yamagishi S, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S, Yoshimura A, Makita Z.

    FASEB J. 2002 Dec;16(14):1928-30. Epub 2002 Oct 4.PMID: 12368225 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.

    Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundörfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP.

    J Clin Invest. 2004 Dec;114(12):1741-51.PMID: 15599399 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.

    Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Fukami K, Okuda S, Imaizumi T.

    Microvasc Res. 2008 Jan;75(1):130-4. Epub 2007 May 18.PMID: 17560613 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.

    Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T.

    Ophthalmic Res. 2007;39(2):92-7. Epub 2007 Feb 2.PMID: 17284935 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.

    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.

    Invest Ophthalmol Vis Sci. 2007 Feb;48(2):858-65.PMID: 17251488 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

    Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

    Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.PMID: 17420349 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

    Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, Taguchi A, Olson K, Bucciarelli L, Goova M, Hofmann MA, Cataldegirmen G, D'Agati V, Pischetsrieder M, Stern DM, Schmidt AM.

    Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):905-10.PMID: 11397695 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.

    Wang X, Diao Y, Zhang H, Huo X, Zhang Q.

    Ann Vasc Surg. 2009 Mar;23(2):246-54. Epub 2008 Dec 24.PMID: 19110400 [PubMed - indexed for MEDLINE]Related articles

    15.

    Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.

    Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H.

    Biochem J. 2003 Mar 15;370(Pt 3):1097-109.PMID: 12495433 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.

    Nishizawa Y, Koyama H.

    J Ren Nutr. 2008 Jan;18(1):76-82. Review.PMID: 18089449 [PubMed - indexed for MEDLINE]Related articles

    17.

    A role for advanced glycation end products in diminished bone healing in type 1 diabetes.

    Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC.

    Diabetes. 2003 Jun;52(6):1502-10.PMID: 12765963 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.

    Duvillié B, Currie C, Chrones T, Bucchini D, Jami J, Joshi RL, Hill DJ.

    Endocrinology. 2002 Apr;143(4):1530-7.PMID: 11897712 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells.

    Lu C, He JC, Cai W, Liu H, Zhu L, Vlassara H.

    Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11767-72. Epub 2004 Aug 2.PMID: 15289604 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Evaluation of advanced glycation end-products in diabetic and inherited canine cataracts.

    Bras ID, Colitz CM, Kusewitt DF, Chandler H, Lu P, Gemensky-Metzler AJ, Wilkie DA.

    Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):249-57.PMID: 16896921 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity